Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-19,000
Closed -$951K 797
2025
Q4
$951K Sell
19,000
-39
-0.2% -$1.88K 0.1% 206
2025
Q3
$934K Buy
19,039
+39
+0.2% +$2K 0.1% 207
2025
Q2
$983K Hold
19,000
0.14% 111
2025
Q1
$761K Buy
+19,000
New +$981K 0.13% 131
2024
Q3
$845K Hold
19,000
0.13% 128
2024
Q2
$764K Hold
19,000
0.12% 127
2024
Q1
$761K Buy
19,000
+12,000
+171% +$451K 0.13% 131
2023
Q4
$264K Buy
+7,000
New +$214K 0.07% 176
2023
Q3
Sell
-7,000
Closed -$212K 186
2023
Q2
$212K Buy
+7,000
New +$205K 0.07% 177

Other funds holding SNV

Inscription Capital's SNV Position: Q1 2026 in Review

Inscription Capital sold out of Synovus (SNV) in Q1 2026, closing a stake of 19,000 shares — an estimated $951K sold.

Inscription Capital first reported a position in SNV in Q2 2023 and held it in 9 quarters. The position peaked at $983K in Q2 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Inscription Capital reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Inscription Capital sold 19,000 Synovus shares in Q1 2026, an estimated $951K.
  • Inscription Capital first reported a position in Synovus in Q2 2023 and held it in 9 quarters.
  • Inscription Capital's Synovus position peaked at $983K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Inscription Capital's 13F filing for Q1 2026, filed 20 Apr 2026.